New brain scan could end misdiagnosis of Parkinson's and tremor

NCT ID NCT04265209

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new PET scan tracer, [18F] LBT-999, to see if it can distinguish Parkinson's disease from essential tremor as well as the current standard SPECT scan. Researchers compared the two imaging methods in 152 patients. If the PET scan works equally well, it could offer a more precise and potentially faster diagnosis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
[18F] LBT-999 (a radioactive tracer for PET imaging)
What this could lead to
If successful, this could provide a more accurate and accessible way to diagnose Parkinson's disease versus essential tremor, helping patients get the right treatment sooner.
What could go wrong
This is a completed Phase 3 study, but the new PET tracer may not prove as effective as the standard SPECT method. Also, PET scanners are less widely available than SPECT, limiting real-world use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ESSENTIAL TREMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHRU Hôpital Bretonneau

    Tours, 37044, France

  • CHU Bordeaux

    Bordeaux, 33076, France

  • CHU La Pitié Salpêtrière

    Paris, 75013, France

  • CHU La Timone

    Marseille, 13005, France

  • CLCC Georges-François Leclerc C.G.F.L

    Dijon, 21000, France

  • Centre Eugène Marquis / CHU Pontchaillou

    Rennes, 35000, France

  • Centre Hospitalier Universitaire de Nîmes

    Nîmes, 30029, France

  • Centre Jean PERRIN / Hôpital Gabriel Montpied (CHU)

    Clermont-Ferrand, 63000, France

  • Hospices Civils de Lyon

    Lyon, 69500, France

  • Hôpital Avicenne

    Bobigny, 93000, France

  • Hôpital Brabois / Hôpital Central (CHRU Nancy)

    Nancy, France

  • Hôpital Henri Mondor

    Créteil, 94010, France

  • Hôpital Laennec (CHU Nantes)

    Nantes, 44093, France

  • Hôpital Pierre Paul Riquet - Purpan (CHU)

    Toulouse, 3100, France

  • Hôpital Roger Salengro (CHRU de Lille)

    Lille, 59037, France

  • Institut de cancérologie Strasbourg Europe

    Strasbourg, 67033, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.